275 related articles for article (PubMed ID: 26051274)
1. Succinate causes α-SMA production through GPR91 activation in hepatic stellate cells.
Li YH; Woo SH; Choi DH; Cho EH
Biochem Biophys Res Commun; 2015 Aug; 463(4):853-8. PubMed ID: 26051274
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 3 (SIRT3) Regulates α-Smooth Muscle Actin (α-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells.
Li YH; Choi DH; Lee EH; Seo SR; Lee S; Cho EH
J Biol Chem; 2016 May; 291(19):10277-92. PubMed ID: 26912655
[TBL] [Abstract][Full Text] [Related]
3. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
4. LY2405319, an analog of fibroblast growth factor 21 ameliorates α-smooth muscle actin production through inhibition of the succinate-G-protein couple receptor 91 (GPR91) pathway in mice.
Le CT; Nguyen G; Park SY; Choi DH; Cho EH
PLoS One; 2018; 13(2):e0192146. PubMed ID: 29444136
[TBL] [Abstract][Full Text] [Related]
5. GPR91 antagonist and TGF-β inhibitor suppressed collagen production of high glucose and succinate induced HSC activation.
Sakai M; Sumiyoshi T; Aoyama T; Urayama K; Yoshimura R
Biochem Biophys Res Commun; 2020 Sep; 530(2):362-366. PubMed ID: 32798017
[TBL] [Abstract][Full Text] [Related]
6. Succinate induces hepatic fibrogenesis by promoting activation, proliferation, and migration, and inhibiting apoptosis of hepatic stellate cells.
Park SY; Le CT; Sung KY; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Feb; 496(2):673-678. PubMed ID: 29366478
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
8. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.
Yang Y; Kim B; Park YK; Koo SI; Lee JY
Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180
[TBL] [Abstract][Full Text] [Related]
9. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
[TBL] [Abstract][Full Text] [Related]
10. Foresight regarding drug candidates acting on the succinate-GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment.
Liang C; Li J; Tian B; Tian L; Liu Y; Li J; Xin L; Wang J; Fu C; Shi Z; Xia J; Liang Y; Wang K
Biomed Pharmacother; 2021 Dec; 144():112298. PubMed ID: 34649219
[TBL] [Abstract][Full Text] [Related]
11. Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling.
Zhang K; Zhang YQ; Ai WB; Hu QT; Zhang QJ; Wan LY; Wang XL; Liu CB; Wu JF
World J Gastroenterol; 2015 Jan; 21(3):878-87. PubMed ID: 25624721
[TBL] [Abstract][Full Text] [Related]
12. Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
Leung C; Herath CB; Jia Z; Goodwin M; Mak KY; Watt MJ; Forbes JM; Angus PW
J Hepatol; 2014 Apr; 60(4):832-8. PubMed ID: 24316518
[TBL] [Abstract][Full Text] [Related]
13. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
[TBL] [Abstract][Full Text] [Related]
14. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
[TBL] [Abstract][Full Text] [Related]
15. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
Trasino SE; Tang XH; Jessurun J; Gudas LJ
J Mol Med (Berl); 2016 Oct; 94(10):1143-1151. PubMed ID: 27271256
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin-2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high-fat diet-fed Ob/Ob mice.
Kim KE; Lee J; Shin HJ; Jeong EA; Jang HM; Ahn YJ; An HS; Lee JY; Shin MC; Kim SK; Yoo WG; Kim WH; Roh GS
Hepatology; 2023 Mar; 77(3):888-901. PubMed ID: 35560370
[TBL] [Abstract][Full Text] [Related]
17. Involvement of cytosolic phospholipase A2 alpha signalling pathway in spontaneous and transforming growth factor-beta-induced activation of rat hepatic stellate cells.
Zhao L; Gandhi CR; Gao ZH
Liver Int; 2011 Nov; 31(10):1565-73. PubMed ID: 22093332
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice.
Yang YL; Kuo HC; Wang FS; Huang YH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917489
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis.
Pulli B; Ali M; Iwamoto Y; Zeller MW; Schob S; Linnoila JJ; Chen JW
Antioxid Redox Signal; 2015 Dec; 23(16):1255-69. PubMed ID: 26058518
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
